home / stock / mson / mson news


MSON News and Press, MISONIX Inc. From 01/17/20

Stock Information

Company Name: MISONIX Inc.
Stock Symbol: MSON
Market: NASDAQ
Website: misonix.com

Menu

MSON MSON Quote MSON Short MSON News MSON Articles MSON Message Board
Get MSON Alerts

News, Short Squeeze, Breakout and More Instantly...

MSON - Misonix (MSON) Investor Presentation - Slideshow

The following slide deck was published by Misonix, Inc. in conjunction with this Read more ...

MSON - Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million

FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc.  (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announ...

MSON - CryoLife and Misonix ink distribution deal for NeoPatch

CryoLife (NYSE: CRY ) has entered into an agreement with Misonix (NASDAQ: MSON ) whereby latter will have exclusive US commercialization rights for CryoLife's NeoPatch product to treat a broad range of indications outside of cardiac and vascular surgery. More news on: CryoLife, Inc....

MSON - CryoLife and Misonix Enter Into Distribution Agreement for NeoPatch

ATLANTA , Dec. 19, 2019 /PRNewswire/ --   CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into an agreement whereby Misonix (NASDAQ: MSON) will  have exclusive US commercializat...

MSON - Misonix to Present at 38th Annual J.P. Morgan Healthcare Conference

FARMINGDALE, N.Y., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc.  (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced to...

MSON - Misonix (MSON) Presents At Piper Jaffray31st Annual Healthcare Conference - Slideshow

The following slide deck was published by Misonix, Inc. in conjunction with this Read more ...

MSON - Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin

FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc.  (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced to...

MSON - Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q1 2020 Results - Earnings Call Transcript

Misonix, Inc. (MSON) Q1 2020 Earnings Conference Call November 7, 2019 16:30 ET Company Participants Norberto Aja - Jaffoni & Collins Stavros Vizirgianakis - President, CEO & Director Joseph Dwyer - CFO, Treasurer & Secretary Conference Call Participants Alexand...

MSON - MISONIX EPS of $0.17

MISONIX (NASDAQ: MSON ): Q1 EPS of $0.17 may not be comparable to consensus of -$0.17. More news on: Misonix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MSON - Misonix Fiscal 2020 First Quarter Record Quarterly Product Revenue Of $11.1 Million

FARMINGDALE, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported fina...

Previous 10 Next 10